Welcome to AusBio

Aus Bio Ltd. is a public but unlisted, Melbourne based biotechnology research and development company (R&D). Principal objectives are:

1. Development of an innovative research program to create new therapeutic products for specific disease states eg influenza.
2. Create significant scientific and commercial alliances.
3. Increase shareholder value.

AGM Meeting 2019

The Aus Bio AGM was held in Melbourne on Friday 22 November 2019 At the conclusion of the meeting Dr Peter Jenkins gave this abbreviated Presentation Of the Company’ results and outlined the way forward

Aus Bio in Bloomberg

“New Drugs are Coming to Fight Nasty Flu Seasons”

Influenza

Aus Bio’s MD2009 project has resulted in the pre-clinical development of a number of antiviral drug candidates which have a different mode of action to the currently used neuraminidase inhibitors.

Respiratory

Aus Bio’s Respiratory Project – MD990 – has resulted from the identification of several specific carbohydrates, which have been shown to influence and enhance recovery of injured human respiratory cells.